Vaughn M. Kailian serves as Executive at MEMORY PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Vaughn M. Kailian has executed 11 insider transactions totaling $30.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 10, 2014 involved selling 600,000 shares valued at $12.0M.
Vaughn M. Kailian currently holds 2,751,048 shares of MEMORY PHARMACEUTICALS CORP (MEMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vaughn M. Kailian has been a net seller of MEMY stock. They have purchased $4.7M and sold $26.2M worth of shares.
Vaughn M. Kailian's most recent insider trade was on Mar 10, 2014, when they sold 600,000 shares at $20.02 per share.
Get notified when new Form 4 filings are submitted
| $27.86 |
| Discretionary |
| Feb 8, 2012 | PCRX | $0 | Conversion | 1,487,680 | $N/A | Discretionary |
| Feb 8, 2012 | PCRX | $1.9M | Purchase | 267,857 | $7.00 | Discretionary |
| Feb 8, 2012 | PCRX | $1.9M | Purchase | 267,857 | $7.00 | Discretionary |
| Feb 8, 2012 | PCRX | $0 | Conversion | 712,567 | $N/A | Discretionary |
| Feb 1, 2012 | VSTM | $0 | Conversion | 1,933,333 | $N/A | Discretionary |
| Feb 1, 2012 | VSTM | $1.0M | Purchase | 100,000 | $10.00 | Discretionary |
| Sep 14, 2007 | MEMY | $58.0K | Sale | 27,600 | $2.10 | Discretionary |
| Sep 13, 2007 | MEMY | $131.8K | Sale | 62,180 | $2.12 | Discretionary |
| Sep 12, 2007 | MEMY | $21.6K | Sale | 10,000 | $2.16 | Discretionary |